Liposomal Delivery Systems: Advanced Nutrient Bioavailability
Liposomal delivery systems are rapidly gaining popularity for their ability to enhance nutrient absorption. With over 65,000 peer-reviewed studies published, liposomes are widely used in medicine to deliver vaccines, hormones, enzymes, vitamins, and botanicals.
Liposomes are tiny lipid bubbles, roughly the width of a human hair, made from phospholipids—the same fats that make up our cell membranes. This unique structure allows them to carry both water- and fat-soluble nutrients. When properly formulated, liposomes can facilitate absorption directly on the tongue, protect nutrients from digestive breakdown, and bypass some of the liver’s first-pass metabolism. Because liposomes closely resemble cell membranes, they can help nutrients access cells more effectively, optimizing cellular support.
Liposomal technology has been likened to the “power of intravenous therapy.” Thanks to enhanced delivery, nutrients in liposomal form may provide equal or greater efficacy at lower doses compared to conventional formulations. For example, liposomal glutathione absorption can approach levels seen with intravenous administration and support intracellular storage. Additionally, the phospholipids themselves are therapeutic, nourishing cell membranes and aiding in toxin removal.
Not all liposomes are created equal. Variations in manufacturing techniques and particle size can significantly affect performance. Liposomes are specialized vesicles engineered to carry nutrients safely and efficiently. When a liposome merges with a cell membrane, it delivers its contents directly into the cell. Smaller liposomes, such as “Ultra-Nano” formulations, demonstrate dramatically higher cellular uptake—one study showed a 34-fold increase when particle size decreased from 236 nm to 64 nm. These particles are smaller than the wavelengths of visible light and are produced using advanced technology.
References
[1]Olthof MR, Hollman PC, et al. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J Nutr, 2000 May;130(5):1200-3. View Abstract
[2]Seeram NP, Lee R, Heber D. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta, 2004 Oct;348(1-2):63-8. View Abstract
[3]Manach C, Williamson G, Morand C, et al. Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailability studies. Am J Clin Nutr, 2005 Jan;81(1 Suppl):230S-42S. View Abstract
[4]Xu JZ, Yeung SY, Chang Q, et al. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr, 2004 Jun;91(6):873-81. View Abstract
[5]Nieves CJ, Montero C, et al. Bioavailability of Herbs and Spices. The FASEB Journal 2009;23:1_supplement, 718.13 View Abstract
[6]Emami S, Azadmard-Damirchi S et al. Liposomes as carrier vehicles for functional compounds in the food sector, Journal of Experimental Nanoscience. 2016.11:9, 737-759. View Full Paper
[7]Taylor TM, Weiss J, et al. Liposomal nanocapsules in food science and agriculture. Crit Rev Food Sci Nutr. 2005;45:587–605 View Full Paper
[8]Silva AC, Santos D, et al. Lipid-based nanocarriers as an alternative for oral delivery of poorly water-soluble drugs: Peroral and mucosal routes. Curr Med Chem. 2012;19(26):4495-4510. View Abstract
[9]Rogers JA, Anderson KE. The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst. 1998;15(5):421-480. View Abstract
[10]Levitskaia TG, Morris JE. Aminothiol receptors for decorporation of intravenously administered (60)Co in the rat. Health Phys. 2010 Jan;98(1):53-60. View Full Paper
[11]Zeevalk GD, Bernard LP Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochem Res. 2010 Oct;35(10):1575-87. View Abstract
[12]Unpublished study on Caco-2 intestinal cells by Quicksilver Scientific,
[13]Hood RR, Andar A, et al. Pharmacy-on-a-chip: Microfluidic synthesis of pegylated and folate receptor-targeted liposomes for drug delivery. 16th International Conference on Miniaturized Systems for Chemistry and Life Sciences. 2012. Okinawa, Japan.
[14]Alexander-Bryant AA, Wen X. Bioengineering Strategies for Designing Targeted Cancer Therapies. In: Advances in Cancer Research, 2013 View Abstract
[15]Smith ME, Morton DG. Digestion And Absorption. In: The Digestive System (Second Edition), 2010
[16]Bawa R. Nanoparticle-based therapeutics in humans: A Survey. Nanotech L&B ,2008;5 : 135–155
[17]Kedar U et al. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine, 6 (6) (2010), pp. 714-729
[18]Shoji Y, Nakashima H. Nutraceutics and delivery systems. J Drug Target, 2004;12(6):385-91.